Figures & data
Table I. Presenting symptoms.
Figure 1. Crude survival related to tumor type.From Abeler et al. [Citation11] with permission.
![Figure 1. Crude survival related to tumor type.From Abeler et al. [Citation11] with permission.](/cms/asset/ce108d74-fe25-4748-bfb6-cd7de4099b12/ionc_a_689111_f0001_b.jpg)
Table II. Staging for uterine sarcomas (leiomyosarcomas, endometrial stromal sarcomas, adenosarcomas, and carcinosarcomas).
Figure 2. Crude survival in leiomyosarcoma confined to uterus. (a) Related to tumor size. (b) Related to number of mitoses per 10 high power fields. (c) Risk grouping based on mitoses and tumor size.
![Figure 2. Crude survival in leiomyosarcoma confined to uterus. (a) Related to tumor size. (b) Related to number of mitoses per 10 high power fields. (c) Risk grouping based on mitoses and tumor size.](/cms/asset/537e484b-40db-4a35-9704-e4556fa960b6/ionc_a_689111_f0002_b.jpg)
Figure 3. Crude survival in ESS. (a) Number of mitoses. (b) Tumor necrosis. (c) ESS risk groups.
From Abeler et al. [Citation11] with permission.
![Figure 3. Crude survival in ESS. (a) Number of mitoses. (b) Tumor necrosis. (c) ESS risk groups.From Abeler et al. [Citation11] with permission.](/cms/asset/7ffcc9dc-a1e4-4ade-96bb-ec528ee24b13/ionc_a_689111_f0003_b.jpg)